The benchmarks show that your dumbass company Way Overpaid for Kyphon at $72 per share. But thanks, because I, and Many other people at Kyphon cashed in thousands and thousands of stock options. I'm Rich, Beeyatch!!!
Commodity product in a commodity market, these type of balloons sell for around $100 in non spine cases
Kyphon dying fast. Stryker gaining so much market share on them. Bonuses are literally paid out on stealing business from MDT this year.
RTG leadership just fired the guy that was responsible for finding and developing the OC bone ablation therapy. Typical RTG leadership trying to reinvent the wheel.
This division has the worst leadership...managers working side deals and jobs = poor outcomes and revenue loss.
SYK IVS is taking a huge dump on Kyphon with the new Spinejack implant. Making balloons look like absolute garbage. Medtronic is bleedin outt...